Published in Neuroscience on March 01, 1996
The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol (2005) 2.64
Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther (2007) 2.51
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol (2010) 1.93
Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct (2008) 1.54
Acute and chronic alcohol dose: population differences in behavior and neurochemistry of zebrafish. Genes Brain Behav (2009) 1.36
Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci U S A (1998) 1.20
Anhedonia and substance dependence: clinical correlates and treatment options. Front Psychiatry (2011) 1.17
A possible mechanism underlying the effectiveness of acupuncture in the treatment of drug addiction. Evid Based Complement Alternat Med (2008) 1.09
The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry (2011) 1.08
Sizing up ethanol-induced plasticity: the role of small and large conductance calcium-activated potassium channels. Alcohol Clin Exp Res (2009) 1.08
Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int Rev Neurobiol (2010) 1.05
Stimulus conditioned to foot-shock stress reinstates alcohol-seeking behavior in an animal model of relapse. Psychopharmacology (Berl) (2002) 1.03
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology (2011) 0.97
In vivo ethanol experience increases D(2) autoinhibition in the ventral tegmental area. Neuropsychopharmacology (2011) 0.95
Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol Disord Drug Targets (2008) 0.92
Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats. Proc Natl Acad Sci U S A (2014) 0.90
Circadian clock genes: effects on dopamine, reward and addiction. Alcohol (2015) 0.86
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets (2010) 0.86
Acupuncture for the treatment of opiate addiction. Evid Based Complement Alternat Med (2012) 0.82
Limited access to ethanol increases the number of spontaneously active dopamine neurons in the posterior ventral tegmental area of nondependent P rats. Alcohol (2010) 0.82
Effect of Withinia Somnifera and Shilajit on Alcohol Addiction in Mice. Pharmacogn Mag (2016) 0.77
Cellular and molecular mechanisms of drug dependence: An overview and update. Indian J Psychiatry (2007) 0.76
GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice. Psychopharmacology (Berl) (2004) 0.76
The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature (1999) 2.91
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci U S A (1993) 1.50
Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology (2004) 1.34
Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther (1995) 1.17
The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochem Int (1999) 1.09
The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor. Br J Pharmacol (1998) 0.99
General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci (1999) 0.97
Benzodiazepine-induced voraciousness in cats and inhibition of amphetamine-anorexia. Life Sci (1976) 0.97
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci (1999) 0.92
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor. Arch Neurol (1978) 0.90
Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol (2008) 0.89
Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. Eur J Pharmacol (1992) 0.89
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology (2000) 0.88
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. Brain Res Mol Brain Res (2001) 0.86
Alpha-amino acid phenolic ester derivatives: novel water-soluble general anesthetic agents which allosterically modulate GABA(A) receptors. J Med Chem (2001) 0.85
[3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes. Neurochem Res (1989) 0.82
Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Curr Neuropharmacol (2007) 0.82
Rewarding and aversive effects of ethanol: interplay of GABA, glutamate and dopamine. Alcohol Alcohol Suppl (1993) 0.82
Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience (1997) 0.81
Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Res (1995) 0.80
Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. Lancet (1998) 0.79
The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. Eur J Pharmacol (2000) 0.78
Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats. Eur J Pharmacol (1999) 0.78
Landfill gas generation after mechanical biological treatment of municipal solid waste. Estimation of gas generation rate constants. Waste Manag (2008) 0.76
Evidence for a dopaminergic control of sympathoadrenal catecholamine release. Am J Cardiol (1988) 0.76
Secretion of growth hormone releasing hormone in obese children. J Endocrinol Invest (1992) 0.76
A review of dark fermentative hydrogen production from biodegradable municipal waste fractions. Waste Manag (2013) 0.76
Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine. Neurochem Res (1993) 0.75
Combined use of a transformed red mud reactive barrier and electrokinetics for remediation of Cr/As contaminated soil. Chemosphere (2011) 0.75
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse (1995) 0.75
Brain dialysis provides evidence for D2-dopamine receptors modulating noradrenaline release in the rat frontal cortex. Eur J Pharmacol (1989) 0.75
Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res (1991) 0.75
Application of accelerated carbonation on MSW combustion APC residues for metal immobilization and CO2 sequestration. J Hazard Mater (2011) 0.75
Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans. Hypertension (1987) 0.75
Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. Eur J Pharmacol (1993) 0.75
Engineering and environmental properties of thermally treated mixtures containing MSWI fly ash and low-cost additives. Chemosphere (2004) 0.75
Dynamic transformations of nitrogen during mechanical-biological pre-treatment of municipal solid waste. Waste Manag (2006) 0.75
Interaction between menstrual cyclicity and gonadotropin pulsatility. Horm Res (1998) 0.75
Two-phase anaerobic digestion within a solid waste/wastewater integrated management system. Waste Manag (2008) 0.75
Rat tyrosine hydroxylase gene polymorphisms. Brain Res Mol Brain Res (1997) 0.75
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. Eur J Pharmacol (1996) 0.75